High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea

被引:196
|
作者
Ko, Kwan Soo
Suh, Ji Yoeun
Kwon, Ki Tae
Jung, Sook-In
Park, Kyong-Hwa
Kang, Cheol In
Chung, Doo Ryeon
Peck, Kyong Ran
Song, Jae-Hoon
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
[3] Asian Pacific Res Fdn Infect Dis ARFID, Seoul 135710, South Korea
[4] Daegu Fatima Hosp, Div Infect Dis, Taegu, South Korea
[5] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
关键词
rpoB; antimicrobial resistance; subgrouping;
D O I
10.1093/jac/dkm305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals. Methods: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method. Results: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively). Conclusions: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 50 条
  • [1] Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance
    Cheah, Soon-Ee
    Li, Jian
    Tsuji, Brian T.
    Forrest, Alan
    Bulitta, Juergen B.
    Nation, Roger L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) : 3921 - 3933
  • [2] Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii
    Caglan, Ecem
    Nigiz, Seyma
    Sancak, Banu
    Gur, Deniz
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2020, 67 (02) : 107 - 111
  • [3] Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates
    Girardello, Raquel
    Visconde, Marina
    Cayo, Rodrigo
    Bressan Queiroz de Figueiredo, Regina Celia
    da Silva Mori, Marcelo Alves
    Lincopan, Nilton
    Gales, Ana Cristina
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (01) : 37 - 44
  • [5] Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
    Lee, Ji-Young
    Chung, Eun Seon
    Ko, Kwan Soo
    SCIENTIFIC REPORTS, 2017, 7
  • [6] Evaluation of colistin and polymyxin B susceptibility testing methods in Klebsiella pneumoniae and Acinetobacter baumannii
    Bakthavatchalam, Yamuna Devi
    Veeraraghavan, Balaji
    Shankar, Abirami
    Thukaram, Bhuvaneswari
    Krishnan, Dhanabhagyam Naveena
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (06): : 504 - 507
  • [7] Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
    Ji-Young Lee
    Eun Seon Chung
    Kwan Soo Ko
    Scientific Reports, 7
  • [8] Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii
    Tsuji, Brian T.
    Landersdorfer, Cornelia B.
    Lenhard, Justin R.
    Cheah, Soon-Ee
    Thamlikitkul, Visanu
    Rao, Gauri G.
    Holden, Patricia N.
    Forrest, Alan
    Bulitta, Jurgen B.
    Nation, Roger L.
    Li, Jian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) : 3913 - 3920
  • [9] Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrugresistant Acinetobacter baumannii isolates
    Wang, Yuan
    Ma, Yingying
    Xiong, Luying
    Wang, Xueting
    Zhou, Yanzi
    Chi, Xiaohui
    Chen, Tao
    Fu, Hao
    Luo, Qixia
    Xiao, Yonghong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (02) : 300 - 308
  • [10] Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
    Kon, Hadas
    Hameir, Amichay
    Temkin, Elizabeth
    Keren-Paz, Alona
    Schwartz, David
    Schechner, Vered
    Carmeli, Yehuda
    MICROORGANISMS, 2022, 10 (01)